Annie Mitsak
Partner at Cure Ventures
About
An experienced investment professional with over 10 years of academic licensing and venture investing experience. Spent six years on the investment team at Omega Funds sourcing and leading investments across oncology, immunology, and rare diseases. Previously worked at MIT's Technology Licensing Office managing patent portfolios and license agreements.
Investments
Board seats
Alessa Therapeutics, Inc.Triton Therapeutics, Inc.
As listed on the firm's website.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Jeno Gyuris
Partner at Cure Ventures